Trademark: 88984241
Word
CYTOVALE
Status
Registered
Status Code
700
Status Date
Tuesday, June 28, 2022
Serial Number
88984241
Registration Number
6775529
Registration Date
Tuesday, June 28, 2022
Mark Type
4
Filing Date
Friday, June 5, 2020
Published for Opposition
Tuesday, September 14, 2021

Trademark Owner History
Cytovale Inc. - Original Registrant

Classifications
9 scientific instruments for biological testing, biological sample processing, scientific research, and laboratory use, namely, automated instruments in the nature of diagnostic apparatus for performing diagnostic assays and automated instruments in the nature of diagnostic apparatus for performing sample preparations; kits comprising scientific instruments, namely, automated instruments in the nature of blood testing apparatus for performing diagnostic assays and automated instruments in the nature of automated blood testing apparatus for performing sample preparations, assays and reagents for biological testing, and for biological sample processing, all for scientific research and laboratory use
44 medical testing and medical analysis for diagnostic or treatment purposes provided by medical laboratories; providing medical information; medical diagnostic testing services; oncological, hematological and sepsis testing services for medical purposes; medical screening services; medical advisory services relating to disease including providing disease risk assessment and related information; comprehensive clinical laboratory medical testing services, namely, anatomic pathology testing, flow cytometry testing, molecular based testing, cytogenetics testing, and fluorescent in situ hybridization (fish) testing
10 medical diagnostic instruments for the analysis of body fluids; medical testing kits for sepsis; blood testing apparatus; medical diagnostic apparatus for carrying-out diagnostic tests for medical purposes, namely, flow cytometry apparatus; apparatus for diagnostic purposes, namely, medical diagnostic apparatus for testing for sepsis and for detecting sepsis; medical apparatuses for the examination and analysis of proteins, peptides, antibodies and molecules for medical diagnostic use and components therefor; diagnostic testing kits comprised of sample testing reagents or consumables for medical use consisting primarily of probes, buffers and reagents for use in microbial testing; medical devices for use in the treatment of sepsis, cancer and other immune-mediated conditions in the fields of oncology, hematology, and for diagnosis and treatment of sepsis; automated medical instruments, namely, host-response testing equipment, cytometers which use electronics and optical fluorescence flow cytometry to analyze human cells; medical micro imaging apparatuses for molecular diagnostics and cytometry for medical diagnostic use and components therefor; digital imaging platforms, namely, medical micro imaging apparatus for acquiring and processing microscopic images for medical diagnostic use; digital imaging platforms, namely, medical micro imaging apparatus for use in the examination of cells, proteins and peptides for medical diagnostic use

Trademark Events
Jun 9, 2020
New Application Entered
Jun 29, 2020
New Application Office Supplied Data Entered
Sep 9, 2020
Assigned To Examiner
Sep 15, 2020
Non-Final Action Written
Sep 15, 2020
Notification Of Non-Final Action E-Mailed
Sep 15, 2020
Non-Final Action E-Mailed
Sep 16, 2020
Teas Change Of Correspondence Received
Sep 16, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 16, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 11, 2021
Teas Response To Office Action Received
Feb 11, 2021
Correspondence Received In Law Office
Feb 12, 2021
Teas/Email Correspondence Entered
Feb 20, 2021
Final Refusal Written
Feb 20, 2021
Notification Of Final Refusal Emailed
Feb 20, 2021
Final Refusal E-Mailed
Aug 12, 2021
Examiner's Amendment Entered
Aug 12, 2021
Notification Of Examiners Amendment E-Mailed
Aug 12, 2021
Examiners Amendment E-Mailed
Aug 12, 2021
Examiners Amendment -Written
Aug 12, 2021
Approved For Pub - Principal Register
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Notification Of Notice Of Publication E-Mailed
Sep 14, 2021
Published For Opposition
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 14, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Noa E-Mailed - Sou Required From Applicant
May 2, 2022
Teas Statement Of Use Received
May 2, 2022
Teas Request To Divide Received
May 2, 2022
Divisional Request Received
May 9, 2022
Sou Teas Extension Received
May 9, 2022
Use Amendment Filed
May 14, 2022
Case Assigned To Intent To Use Paralegal
May 19, 2022
Divisional Processing Complete
May 19, 2022
Statement Of Use Processing Complete
May 25, 2022
Allowed Principal Register - Sou Accepted
May 26, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 28, 2022
Registered-Principal Register
Jun 28, 2022
Notice Of Registration Confirmation Emailed

Trademark Alertz updated from USPTO on 2030-01-24